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A new family of antibacterial antibiotics has been isolated from Micromonospora citrea. The compounds, designated citreamicins a, /?, y, £ and rj are of the polycyclic xanthone structure type. Their isolation, characterization and structure determination are presented.
The citreamicin antibiotic complex is produced by a recently described subspecies of Micromonospora citrea1]. As antimicrobial agents, these compoundsare effective in vitro against a spectrum of Gram-positive aerobic and anaerobic bacteria. Citreamicin rj is the most potent congener with in vitro MICvalues < 0.015 //g/ml against several Gram-positive strains. The compoundsare structurally related to a small family of antibiotics including cervinomycin2), simaomicin3), lysolipin4), and actinoplanone5). The citreamicins are the first examples of this class to be reported from Micromonospora,and are only the second example of the structure type to have a quinone ring fused to the pyrone. In this report are presented the isolation, characterization, and structure determination of citreamicins a, p, y, £ and rj (l~5)n.
Materials and Methods

NMR Experiments
The carbon detected long range heteronuclear correlation experiment (CSCMLR)7) was performed on a GE500 MHzspectrometer. Initial spectral acquisition parameters were: 25,641 Hz sweep width in the F2 dimension; 512 spectra (44 scans each) were accumulated with a 1.0-second relaxation delay and 0.250msecond increments starting with a 0.125-msecond delay, with 12.52Hz/pt resolution in the F2 dimension and 7.8 Hz/pt in the Ft dimension.
f These compounds were previously designated the LL-E19085 antibiotics. * f The structure ofcitreamicin a represents a revision of the original structure disclosed in our previous reports* à"6).
Tank Fermentation and Processing
505
Inoculum for the fermentation was developed in three stages of 48 hours each at 32°C in a seed medium consisting of (g/liter):
Glucose (10), dextrin (20), yeast extract (5), NZ Amine A (5), and CaCO3 (1). The final stage (300 liters) was used to inoculate 2,700 liters of sterilized fermentation medium consisting of (g/liter):
Dextrin (30), glucose (5), Nutrisoy (15), corn steep liquor (5) and CaCO3 (5). The tank was stirred at HOrpmwith aeration at 0.60 v/v/m at 28°C for 103 hours when it was harvested. The harvest potency of citreamicin a was 120jug/ml by HPLCanalysis. The antibiotic complex was recovered by extraction of the acidified (pH 3.0) fermentation mediumwith an equal volume of ethyl acetate. The resulting organic phase was concentrated to a syrupy residue under reduced pressure.
Analytical HPLC The analytical HPLCsystem consisted ofa C18 reversed-phase column (3 /mi, 2. 1 x 100 mm)eluted with a 3 : 2 mixture of acetonitrile and 0.05 m pH 4.5 ammoniumacetate buffer at 0.5 ml/minute. Detection was by UVabsorbance at 325nm. Retention times of the citreamicins were as follows: a, 2.9 minutes; /?, 2.4 minutes; y, 1.6 minutes; C, 1-9 minutes and rj, 1.2 minutes.
Chromatographic Purification
The chromatographic purification of the antibiotics is outlined in the flow diagram shown in Fig. 1 . A portion of the crude extract containing 9.7g of citreamicin a was dissolved in methylene chloride (2,000 ml). To this solution was added silica gel (63~200 /mi, 500 g). After stirring thoroughly, the solvent was removed under reduced pressure. The charged silica was air dried and then eluted on a coarse sintered glass funnel sequentially with hexane (3,000 ml) and methylene chloride (3,000 ml). The first 1 ,000 ml from methylene chloride elution contained the bulk of the antibiotics (8.4 g citreamicin a). This fraction was concentrated, redissolved in methylene chloride (500 ml) and chromatographed on a silica gel (63~200 /mi, 800 g) column packed in methylene chloride. The column was eluted with methylene chloride (12,000 ml) followed by acetone -methylene chloride (1 : 9, 2,000 ml). Fractions were analyzed by analytical HPLCand combined accordingly. Citreamicin a (6.5g) was obtained as were mixtures I, II, and III, which were enriched in the more polar minor components. 
Isolation of Citreamicins ft and y
A portion offraction I was separated by reversed-phase HPLCto obtain small quantities ofcitreamicins P and y. Thus, a solution of I in acetonitrile (ca. lOmg/ml) was chromatographed (2~4ml/injection) on a C18 column (10^m, 21.4mm x 25cm) eluted with a mixture of acetonitrile-0.05m pH4.5 ammonium acetate (3 : 2). From three runs (9 ml total injected), approximately 4mg each of citreamicins /? and y were obtained.
Isolation of Citreamicin C Fraction II was dissolved in acetonitrile (100 mg/10 ml). This solution was chromatographed on a C18 reversed-phase column (55~105 /mi, 400 g) eluted with a mixture of acetonitrile -0.05 m pH 4.5 ammonium acetate buffer (1 : 1), to obtain citreamicin £ (28 mg).
Isolation of Citreamicin w
Fraction III (100 mg) dissolved in acetonitrile (10 ml) was chromatographed in the 1 : 1 system described above, yielding citreamicin rj (15 mg). Citreamicin r\\ [a]£6 -63°(c 0.190, DMSO).
Basic Degradation of Citreamicin a
Citreamicin a#(1 10 mg) was dissolved in a mixture of methanol (10 ml) and methylene chloride (2 ml). To this solution was added 1.0n NaOH(1.0ml), and the mixture was stirred at room temperature for 90 minutes. The reaction mixture was then acidified to pH 2.5 with 1.0 n HC1, and diluted with water (10ml). The crude product was extracted into methylene chloride (3 x 25 ml). Uponevaporation of the solvent, the residue weighed 50 mg. This material was purified by Sephadex LH-20 chromatography. Fresh Sephadex LH-20 was treated with a solvent system consisting ofmethylene chloride, hexane, and methanol (10 : 5 : 2) and after swelling of the gel was complete, a column was formed (2.8 x 39cm). The crude product was chromatographed on this column with the same solvent system. Fractions were collected (8 ml Acidic Methanolysis of Citreamicin a Citreamicin a (lOOmg) was dissolved in methanol (500ml). A solution of 3% HC1 in methanol (25 ml) was added and the solution was refluxed for 66.5 hours. The solvent was evaporated under reduced pressure and the residue was redissolved in methylene chloride (100 ml). The methylene chloride solution was washed sequentially with 5% NaHCO3(50ml) and water (50ml). Removal of the solvent under reduced pressure left the product alcohol 5 (70 mg), which was shown to be identical with citreamicin rj in HPLC, *H and 13C NMR, and FAB-MS.
Results and Discussion
Isolation and Characterization Whole mash from tank fermentations of the organism was adjusted to pH 3,0 and then extracted with ethyl acetate. The resulting organic extract was concentrated to a syrup under reduced pressure. This syrup was stirred with hexane and filtered to removenonpolar impurities prior to chromatography. Twostages of silica gel chromatography (Fig. 1) yielded the major component, citreamicin a, in relatively pure form (85%). The minor components required a reversed-phase chromatographic step to complete their purification.
Selected physico-chemical properties of the citreamicins are summarized in Table 1 . These compounds are highly colored pH indicators, yielding yellow to red solution under acidic or neutral conditions, which turn green when the solution is made basic. The poor solubility of these compounds was the limiting factor in their isolation and purification. The compoundsare soluble in chloroform, methylene chloride, and acetone to the extent of approximately 100 mg/ml. Solubility in acetonitrile, ethyl acetate, methanol and ethanol was lower, on the order of approximately 10mg/ml. Gel formation was commonin the more polar solvents whensaturated solutions were allowed to stand for several hours at roomtemperature.
The molecular formulas for the citreamicins were established by HRFAB-MS. The accurate mass measurements were done on the (M + 3H)+ molecular adduct ions, since the antibiotics were converted to their hydroquinone analogs in the mass spectrometer under most experimental conditions. This reduction phenomenon in FAB-MSis now well documented for quinones8). The UV-VIS spectrum of the a component (Fig. 2) is typical of the citreamicins and shows several sharp absorption bands in the UV region with maxima at 223, 255, 320, and 384nm plus a broad visible band centered at 410nm. This curve is very similar to the spectrum of cervinomycin A22). The IR spectrum of citreamicin <x (Fig. 3 ) contains significant bands attributed to hydrogen bonded OH (3440cm"1), and several carbonyl signals. The band at 1746cm"1 was considered to be due to a simple aliphatic ester group. The highest frequency carbonyl absorption at 1804cm" 1 was identified as being characteristic of this series of compounds, and a review of the literature failed to reveal any related antibiotics with this unusual IR absorption. This was one of the earliest indications that the citreamicins were novel.
The NMRdata for the citreamicins are summarized in Table 2 . Citreamicin a is the major component produced by the culture and the other components represent simple structural variants of it, hence the NMRdata for citreamicin a will be used to exemplify the properties of the group. In its 13C NMR spectrum (Fig. 4) , there are signals representing twenty-four sp2 hybridized carbons between 100~1 82 ppm; nineteen of these are due to quaternary carbons. In the 1H NMRspectrum (Fig. 5) , only two of the five aromatic proton signals showed connectivity. These (S 7.92 and 8.20 (.7= 8. Structure Determination of Citreamicins a and rj Given the spectroscopic similarities noted above between these antibiotics and the lysolipin class, and in particular cervinomycin A2 (6), the partial structure 7 shown in Fig. 6 was proposed. Support for 7 was obtained by isolation of methyl 4,5-dimethoxysalicylate from methanolic base degradation of citreamicin a. This product is derived from fission of the pyrone (F) ring. Connectivity to the C ring was established through a crosspeak between C-27 and 7-H 3 7.19. The 7-H resonance showed additional crosspeaks to 3 140.7 (C-8) and 119.9 (C-25). The latter signal was correlated with the phenol proton resonance 3 13.5, as were C-26 3 162.1 and C-27, thus completing the connections of ring C. The link between the C and D rings was made through the observed crosspeaks between 9-H 3 7.92 and C-25, as well as 10-H 3 8.20 and C-8. The signal for 9-H also showed a crosspeak to 3 129.7 (C-ll) as did 10-H with 3 137.7 (C-24) and 3 178.1 (C-12), thus linking the D and E rings.
Owingto the lack of protons, no direct correlations were observed between the quinone (E) and pyrone The remaining portions of the structure (Fig. 7) of citreamicin a, which represent the novel features of these antibiotics, were assigned on the basis of spectroscopic and chemical evidence. Acidic methanolysis of citreamicin a resulted in primary alcohol 5, indicating loss of a C5H9Ounit. This moiety was identified as an isovaleryl group by comparison of the XHNMRdata for 5 with those for citreamicin a. In the XH NMRspectrum of citreamicin a (Fig. 5) 3'a, 4'-CH3 ). These signals are lacking in the spectrum of 5, which also shows a substantial upfleld shift for one set of methylene protons (3 3.90 and 4.33, br d, /= 10.1 Hz). Compound 5 (citreamicin r\) has lost the IR band at 1746cm"1 characteristic of the aliphatic ester group ofcitreamicin a, but still retains the high frequency carbonyl band (1798 cm" 1). In addition to this carbonyl group, three carbons remained to be incorporated into the final structure of 5, one quaternary (3 63.4), one C-methyl group (<5C 19.0; 3H 1.83, s), and the primary alcohol carbon (3C 65.8; 3H 3.90, 1H, d, /= 10.1 Hz, 4.33, 1H, d, /= 10.1 Hz). These carbons and the remaining unsaturation required by the molecular formula are best accommodated by the oxazolidinone moiety shown in the A-ring partial structure of Fig. 7 . The lactone group of this moiety should have a high frequency carbonyl stretching band in the IR9). For example, simple oxazolidinones synthesized from amino acid derivatives and aldehydes have been reported10* showing this characteristic IR band near 1800cm" 1. Evidence for this A-ring structure was also obtained from the CSCMLR data for citreamicin a. Thus, the C-la proton resonance 3 1.83 showed crosspeaks with 3 62.3 (C-l), 65.0 (C-lb) and 171.5 (C-2). The C-lb proton signals (3 4.46, 4.78) each showed crosspeaks to C-2, and one of these (3 4 .78) showed a crosspeak to C-l. This analysis allowed the formulation of structure 1 for citreamicin a and hence that of primary alcohol 5, which was identical with the natural product citreamicin r\.
Structure Determination of Citreamicins /?, y and f Acidic methanolysis of citreamicins /? and y yielded primary alcohol 5, thus confirming the identity of the core portions of their structures with that of 1. The structures of their ester side chains were established by XH NMR.By subtracting the elements of 5 from their molecular formulas, the acyl side chains of citreamicins ft and y were determined to consist of C4H9Oand C2H3O, respectively. The isobutyryl group ofcitreamicin /? was assigned from the XH NMRdata as follows: 3 2.55, 1H, septet, /=7.0Hz, 2'-H; 1.19, 3H, d, /=7.0Hz, 2'a-CH3; 1.18, 3H, d, /=7.0Hz, 2'b-CH3. Therefore structure 2 was established for citreamicin /?. For citreamicin y, the three-proton singlet in the XHNMRspectrum at 3 2.10 clearly identified the acetyl group, and led to assignment of structure 3.
Citreamicin f was shown to be a lower homolog of 1 by FAB-MSanalysis. The XH NMRspectrum of citreamicin £ showed just one OCH3signal (3 4.06), suggesting that one of the G-ring OCH3 groups was absent. Comparison of the NMRdata for citreamicin ( with those of 1 revealed some significant differences. The 19-H signal of citreamicin £ is shifted down field by 0.17ppm to 3 7.75, while the 16-H resonance shifted by only 0.05ppm. In the 13C NMRspectrum of citreamicin f, the C-l8 signal appears at 3 146.3, a shift of 2.4ppm up field, and the C-19 signal has moved down field 3.5ppm to 3 108. 4 . The signals for C-l7 and C-l6 are only slightly shifted. These results indicate that it is the 18-OCH3 group which is absent and therefore citreamicin f was assigned structure 4.
Citreamicins a, /?, y, f, and rj (1~5) represent highly modified A-ring variants of cervinomycin A2. These compounds are unusual members of the lysolipin class in that they lack the methylenedioxy function and have quinone rings fused to the pyrone ring. These antibiotics are the first members of this structure class to be reported from Micromonospora.Theculture produces a numberof other componentswith homologous side chains which have not been fully characterized. It is noteworthy that 5 was the only monomethoxylatedproduct discovered in the course of this work. There was no evidence for the production of the corresponding 17-OHanalogue or the didemethoxy compound.
